Trials / Completed
CompletedNCT00203125
A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.
Sub-study to Evaluate the Effect of An Oral Dose of Tyramine in Subjects Completing 26 Weeks of Participation in PRESTO (TVP-1012/133)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is to determine if Tyramine has any side effects on patients receiving 0.5mg, 1mg of Rasagiline or Placebo
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | rasagiline mesylate | 0.5 or 1 mg oral, once-daily |
| OTHER | tyramine | 50 mg once daily |
Timeline
- Start date
- 2000-10-01
- Primary completion
- 2003-01-01
- Completion
- 2003-01-01
- First posted
- 2005-09-20
- Last updated
- 2011-04-12
Source: ClinicalTrials.gov record NCT00203125. Inclusion in this directory is not an endorsement.